Tags

Type your tag names separated by a space and hit enter

Chronic Treatment with Ivabradine Does Not Affect Cardiovascular Autonomic Control in Rats.
Front Physiol. 2016; 7:305.FP

Abstract

A low resting heart rate (HR) would be of great benefit in cardiovascular diseases. Ivabradine-a novel selective inhibitor of hyperpolarization-activated cyclic nucleotide gated (HCN) channels- has emerged as a promising HR lowering drug. Its effects on the autonomic HR control are little known. This study assessed the effects of chronic treatment with ivabradine on the modulatory, reflex and tonic cardiovascular autonomic control and on the renal sympathetic nerve activity (RSNA). Male Wistar rats were divided in 2 groups, receiving intraperitoneal injections of vehicle (VEH) or ivabradine (IVA) during 7 or 8 consecutive days. Rats were submitted to vessels cannulation to perform arterial blood pressure (AP) and HR recordings in freely moving rats. Time series of resting pulse interval and systolic AP were used to measure cardiovascular variability parameters. We also assessed the baroreflex, chemoreflex and the Bezold-Jarish reflex sensitivities. To better evaluate the effects of ivabradine on the autonomic control of the heart, we performed sympathetic and vagal autonomic blockade. As expected, ivabradine-treated rats showed a lower resting (VEH: 362 ± 16 bpm vs. IVA: 260 ± 14 bpm, p = 0.0005) and intrinsic HR (VEH: 369 ± 9 bpm vs. IVA: 326 ± 11 bpm, p = 0.0146). However, the chronic treatment with ivabradine did not change normalized HR spectral parameters LF (nu) (VEH: 24.2 ± 4.6 vs. IVA: 29.8 ± 6.4; p > 0.05); HF (nu) (VEH: 75.1 ± 3.7 vs. IVA: 69.2 ± 5.8; p > 0.05), any cardiovascular reflexes, neither the tonic autonomic control of the HR (tonic sympathovagal index; VEH: 0.91± 0.02 vs. IVA: 0.88 ± 0.03, p = 0.3494). We performed the AP, HR and RSNA recordings in urethane-anesthetized rats. The chronic treatment with ivabradine reduced the resting HR (VEH: 364 ± 12 bpm vs. IVA: 207 ± 11 bpm, p < 0.0001), without affecting RSNA (VEH: 117 ± 16 vs. IVA: 120 ± 9 spikes/s, p = 0.9100) and mean arterial pressure (VEH: 70 ± 4 vs. IVA: 77 ± 6 mmHg, p = 0.3293). Our results suggest that, in health rats, the long-term treatment with ivabradine directly reduces the HR without changing the RSNA modulation and the reflex and tonic autonomic control of the heart.

Authors+Show Affiliations

Laboratory of Cardiovascular Physiology, Department of Biological Sciences, Institute of Exact and Biological Sciences, Federal University of Ouro PretoOuro Preto, Brazil; Graduate Program in Biological Sciences - CBIOL/NUPEB, Federal University of Ouro PretoOuro Preto, Brazil.Laboratory of Cardiovascular Physiology, Department of Biological Sciences, Institute of Exact and Biological Sciences, Federal University of Ouro PretoOuro Preto, Brazil; Graduate Program in Biological Sciences - CBIOL/NUPEB, Federal University of Ouro PretoOuro Preto, Brazil.Laboratory of Hypertension, Institute of Biological Sciences, Department of Physiology and Biophysics, Federal University of Minas Gerais Belo Horizonte, Brazil.Laboratory of Cardiovascular Physiology, Department of Biological Sciences, Institute of Exact and Biological Sciences, Federal University of Ouro Preto Ouro Preto, Brazil.Laboratory of Hypertension, Institute of Biological Sciences, Department of Physiology and Biophysics, Federal University of Minas Gerais Belo Horizonte, Brazil.Laboratory of Cardiovascular Physiology, Department of Biological Sciences, Institute of Exact and Biological Sciences, Federal University of Ouro PretoOuro Preto, Brazil; Graduate Program in Biological Sciences - CBIOL/NUPEB, Federal University of Ouro PretoOuro Preto, Brazil.Laboratory of Biomedical Engineering, Institute of Science and Technology, Federal University of São Paulo São José dos Campos, Brazil.Department of Physiology, University of Uberaba Uberaba, Brazil.Department of Clinical Sciences and Community Health, IRCCS Ca' Granda Foundation, Ospedale Maggiore Policlinico, University of Milan Milan, Italy.Department of Clinical Sciences and Community Health, IRCCS Ca' Granda Foundation, Ospedale Maggiore Policlinico, University of Milan Milan, Italy.Department of Clinical Sciences and Community Health, IRCCS Ca' Granda Foundation, Ospedale Maggiore Policlinico, University of Milan Milan, Italy.Department of Physiology, Institute of Biological and Natural Sciences, Federal University of Triângulo Mineiro Uberaba, Brazil.Laboratory of Cardiovascular Physiology, Department of Biological Sciences, Institute of Exact and Biological Sciences, Federal University of Ouro PretoOuro Preto, Brazil; Graduate Program in Biological Sciences - CBIOL/NUPEB, Federal University of Ouro PretoOuro Preto, Brazil.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

27507948

Citation

Silva, Fernanda C., et al. "Chronic Treatment With Ivabradine Does Not Affect Cardiovascular Autonomic Control in Rats." Frontiers in Physiology, vol. 7, 2016, p. 305.
Silva FC, Paiva FA, Müller-Ribeiro FC, et al. Chronic Treatment with Ivabradine Does Not Affect Cardiovascular Autonomic Control in Rats. Front Physiol. 2016;7:305.
Silva, F. C., Paiva, F. A., Müller-Ribeiro, F. C., Caldeira, H. M., Fontes, M. A., de Menezes, R. C., Casali, K. R., Fortes, G. H., Tobaldini, E., Solbiati, M., Montano, N., Dias Da Silva, V. J., & Chianca, D. A. (2016). Chronic Treatment with Ivabradine Does Not Affect Cardiovascular Autonomic Control in Rats. Frontiers in Physiology, 7, 305. https://doi.org/10.3389/fphys.2016.00305
Silva FC, et al. Chronic Treatment With Ivabradine Does Not Affect Cardiovascular Autonomic Control in Rats. Front Physiol. 2016;7:305. PubMed PMID: 27507948.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Chronic Treatment with Ivabradine Does Not Affect Cardiovascular Autonomic Control in Rats. AU - Silva,Fernanda C, AU - Paiva,Franciny A, AU - Müller-Ribeiro,Flávia C, AU - Caldeira,Henrique M A, AU - Fontes,Marco A P, AU - de Menezes,Rodrigo C A, AU - Casali,Karina R, AU - Fortes,Gláucia H, AU - Tobaldini,Eleonora, AU - Solbiati,Monica, AU - Montano,Nicola, AU - Dias Da Silva,Valdo J, AU - Chianca,Deoclécio A,Jr Y1 - 2016/07/26/ PY - 2016/05/13/received PY - 2016/07/06/accepted PY - 2016/8/11/entrez PY - 2016/8/11/pubmed PY - 2016/8/11/medline KW - HCN channels KW - cardiovascular reflexes KW - ivabradine KW - renal sympathetic nerve activity KW - sympathetic activity KW - tonic control KW - vagal activity SP - 305 EP - 305 JF - Frontiers in physiology JO - Front Physiol VL - 7 N2 - A low resting heart rate (HR) would be of great benefit in cardiovascular diseases. Ivabradine-a novel selective inhibitor of hyperpolarization-activated cyclic nucleotide gated (HCN) channels- has emerged as a promising HR lowering drug. Its effects on the autonomic HR control are little known. This study assessed the effects of chronic treatment with ivabradine on the modulatory, reflex and tonic cardiovascular autonomic control and on the renal sympathetic nerve activity (RSNA). Male Wistar rats were divided in 2 groups, receiving intraperitoneal injections of vehicle (VEH) or ivabradine (IVA) during 7 or 8 consecutive days. Rats were submitted to vessels cannulation to perform arterial blood pressure (AP) and HR recordings in freely moving rats. Time series of resting pulse interval and systolic AP were used to measure cardiovascular variability parameters. We also assessed the baroreflex, chemoreflex and the Bezold-Jarish reflex sensitivities. To better evaluate the effects of ivabradine on the autonomic control of the heart, we performed sympathetic and vagal autonomic blockade. As expected, ivabradine-treated rats showed a lower resting (VEH: 362 ± 16 bpm vs. IVA: 260 ± 14 bpm, p = 0.0005) and intrinsic HR (VEH: 369 ± 9 bpm vs. IVA: 326 ± 11 bpm, p = 0.0146). However, the chronic treatment with ivabradine did not change normalized HR spectral parameters LF (nu) (VEH: 24.2 ± 4.6 vs. IVA: 29.8 ± 6.4; p > 0.05); HF (nu) (VEH: 75.1 ± 3.7 vs. IVA: 69.2 ± 5.8; p > 0.05), any cardiovascular reflexes, neither the tonic autonomic control of the HR (tonic sympathovagal index; VEH: 0.91± 0.02 vs. IVA: 0.88 ± 0.03, p = 0.3494). We performed the AP, HR and RSNA recordings in urethane-anesthetized rats. The chronic treatment with ivabradine reduced the resting HR (VEH: 364 ± 12 bpm vs. IVA: 207 ± 11 bpm, p < 0.0001), without affecting RSNA (VEH: 117 ± 16 vs. IVA: 120 ± 9 spikes/s, p = 0.9100) and mean arterial pressure (VEH: 70 ± 4 vs. IVA: 77 ± 6 mmHg, p = 0.3293). Our results suggest that, in health rats, the long-term treatment with ivabradine directly reduces the HR without changing the RSNA modulation and the reflex and tonic autonomic control of the heart. SN - 1664-042X UR - https://www.unboundmedicine.com/medline/citation/27507948/Chronic_Treatment_with_Ivabradine_Does_Not_Affect_Cardiovascular_Autonomic_Control_in_Rats_ L2 - https://doi.org/10.3389/fphys.2016.00305 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.